Uni-Bio Science Group Limited (HKG:0690)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.110
+0.002 (1.85%)
At close: Mar 11, 2026
46.67%
Market Cap 656.84M
Revenue (ttm) 589.59M
Net Income (ttm) 91.35M
Shares Out 5.97B
EPS (ttm) 0.02
PE Ratio 7.28
Forward PE n/a
Dividend 0.00 (2.56%)
Ex-Dividend Date n/a
Volume 2,239,999
Average Volume 3,823,200
Open 0.108
Previous Close 0.108
Day's Range 0.106 - 0.110
52-Week Range 0.055 - 0.168
Beta -0.11
RSI 48.78
Earnings Date Mar 27, 2026

About Uni-Bio Science Group

Uni-Bio Science Group Limited, an investment holding company, researches and develops, manufactures, and sells biological and chemical pharmaceutical products to treat human diseases in the People’s Republic of China. It operates through Chemical Pharmaceutical Products, Biological Pharmaceutical Products, and Pipeline Products segments. The company provides BOGUTAI, a disposable injection pen for the treatment of osteoporosis; GeneTime, a prescription biological drug for wound healing; GeneSoft, a therapeutic drug for dry eye syndrome, corneal... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2001
Employees 504
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 0690
Full Company Profile

Financial Performance

In 2024, Uni-Bio Science Group's revenue was 552.98 million, an increase of 14.08% compared to the previous year's 484.72 million. Earnings were 82.77 million, an increase of 16.79%.

Financial Statements